Menu
GeneBe

rs9986447

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000287.4(PEX6):c.883-3T>C variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 1,609,494 control chromosomes in the GnomAD database, including 148,312 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 10783 hom., cov: 31)
Exomes 𝑓: 0.43 ( 137529 hom. )

Consequence

PEX6
NM_000287.4 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.0002058
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.428
Variant links:
Genes affected
PEX6 (HGNC:8859): (peroxisomal biogenesis factor 6) This gene encodes a member of the AAA (ATPases associated with diverse cellular activities) family of ATPases. This member is a predominantly cytoplasmic protein, which plays a direct role in peroxisomal protein import and is required for PTS1 (peroxisomal targeting signal 1, a C-terminal tripeptide of the sequence ser-lys-leu) receptor activity. Mutations in this gene cause peroxisome biogenesis disorders of complementation group 4 and complementation group 6. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 6-42975041-A-G is Benign according to our data. Variant chr6-42975041-A-G is described in ClinVar as [Benign]. Clinvar id is 92791.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-42975041-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.449 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PEX6NM_000287.4 linkuse as main transcriptc.883-3T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000304611.13

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PEX6ENST00000304611.13 linkuse as main transcriptc.883-3T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_000287.4 P1Q13608-1
PEX6ENST00000244546.4 linkuse as main transcriptc.883-3T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 Q13608-2

Frequencies

GnomAD3 genomes
AF:
0.362
AC:
54812
AN:
151618
Hom.:
10782
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.230
Gnomad AMI
AF:
0.583
Gnomad AMR
AF:
0.324
Gnomad ASJ
AF:
0.408
Gnomad EAS
AF:
0.104
Gnomad SAS
AF:
0.403
Gnomad FIN
AF:
0.405
Gnomad MID
AF:
0.396
Gnomad NFE
AF:
0.453
Gnomad OTH
AF:
0.383
GnomAD3 exomes
AF:
0.373
AC:
93610
AN:
251010
Hom.:
19174
AF XY:
0.387
AC XY:
52530
AN XY:
135698
show subpopulations
Gnomad AFR exome
AF:
0.228
Gnomad AMR exome
AF:
0.252
Gnomad ASJ exome
AF:
0.414
Gnomad EAS exome
AF:
0.105
Gnomad SAS exome
AF:
0.424
Gnomad FIN exome
AF:
0.402
Gnomad NFE exome
AF:
0.449
Gnomad OTH exome
AF:
0.409
GnomAD4 exome
AF:
0.427
AC:
622873
AN:
1457760
Hom.:
137529
Cov.:
34
AF XY:
0.430
AC XY:
311688
AN XY:
725384
show subpopulations
Gnomad4 AFR exome
AF:
0.224
Gnomad4 AMR exome
AF:
0.264
Gnomad4 ASJ exome
AF:
0.413
Gnomad4 EAS exome
AF:
0.125
Gnomad4 SAS exome
AF:
0.432
Gnomad4 FIN exome
AF:
0.394
Gnomad4 NFE exome
AF:
0.453
Gnomad4 OTH exome
AF:
0.408
GnomAD4 genome
AF:
0.361
AC:
54841
AN:
151734
Hom.:
10783
Cov.:
31
AF XY:
0.358
AC XY:
26570
AN XY:
74154
show subpopulations
Gnomad4 AFR
AF:
0.230
Gnomad4 AMR
AF:
0.324
Gnomad4 ASJ
AF:
0.408
Gnomad4 EAS
AF:
0.105
Gnomad4 SAS
AF:
0.404
Gnomad4 FIN
AF:
0.405
Gnomad4 NFE
AF:
0.453
Gnomad4 OTH
AF:
0.381
Alfa
AF:
0.400
Hom.:
6878
Bravo
AF:
0.346
Asia WGS
AF:
0.250
AC:
870
AN:
3478
EpiCase
AF:
0.457
EpiControl
AF:
0.459

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicOct 21, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 07, 2018- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 10, 2016Variant summary: The PEX6 c.883-3T>C variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. This variant was found in 45827/121356 control chromosomes (9493 homozygotes) at a frequency of 0.3776245, which greatly exceeds the estimated maximal expected allele frequency of a pathogenic PEX6 variant (0.0019365), indicating that this variant is a benign polymorphism. Multiple clinical labs have classified the variant as benign. Taken together, this variant is classified as benign. -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 23, 2013- -
Peroxisome biogenesis disorder 4A (Zellweger) Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Peroxisome biogenesis disorder 4A (Zellweger);C3553937:Peroxisome biogenesis disorder 4B;C4225267:Heimler syndrome 2 Benign:1
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsAug 11, 2021- -
Heimler syndrome 2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Zellweger spectrum disorders Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Peroxisome biogenesis disorder Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Peroxisome biogenesis disorder 4B Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
Cadd
Benign
8.3
Dann
Benign
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00021
dbscSNV1_RF
Benign
0.016
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs9986447; hg19: chr6-42942779; COSMIC: COSV55103559; API